# Do Endotypes Predict Response and Sequelae in OSA Patients

> **NCT04875364** · PHASE2 · RECRUITING · sponsor: **University of California, San Diego** · enrollment: 200 (estimated)

## Conditions studied

- Obstructive Sleep Apnea
- Sleep Apnea
- Sleep Apnea, Obstructive
- Sleep
- Sleep Disorder

## Interventions

- **DRUG:** Eszopiclone
- **OTHER:** Supplemental Oxygen
- **DEVICE:** Continuous Positive Airway Pressure (CPAP)

## Key facts

- **NCT ID:** NCT04875364
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-08-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04875364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04875364, "Do Endotypes Predict Response and Sequelae in OSA Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04875364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*